Tyme Technologies, Inc. [TYME]

Source: 

Company Overview

TYME is an emerging biotechnology company developing CMBTs that are intended to be effective across a broad range of solid tumors and hematologic cancers, while also maintaining patients quality of life through relatively low toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Companys therapeutic approach is designed to take advantage of a cancer cells innate metabolic requirements to cause cancer cell death.